CY1111974T1 - Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπους - Google Patents
Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπουςInfo
- Publication number
- CY1111974T1 CY1111974T1 CY20111101007T CY111101007T CY1111974T1 CY 1111974 T1 CY1111974 T1 CY 1111974T1 CY 20111101007 T CY20111101007 T CY 20111101007T CY 111101007 T CY111101007 T CY 111101007T CY 1111974 T1 CY1111974 T1 CY 1111974T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmacologically active
- detergent compositions
- compositions
- fat removal
- useful
- Prior art date
Links
- 239000003599 detergent Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 206010049287 Lipodystrophy acquired Diseases 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 210000000744 eyelid Anatomy 0.000 abstract 1
- 208000006132 lipodystrophy Diseases 0.000 abstract 1
- 238000007443 liposuction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Συνθέσεις και μέθοδοι χρήσιμες στη μη-χειρουργική αφαίρεση εντοπισμένων εναποθέσεων λίπους σε ασθενείς οι οποίοι την έχουν ανάγκη χρησιμοποιώντας φαρμακολογικώς δραστικά απορρυπαντικά γνωστοποιούνται. Οι συνθέσεις φαρμακολογικώς δραστικών απορρυπαντικών μπορεί επιπροσθέτως να περιλαμβάνουν αντι-φλεγμονώδεις παράγοντες, αναλγητικά, παράγοντες διασποράς και φαρμακευτικώς αποδεκτά έκδοχα αλλά δεν περιέχουν φωσφατιδυλοχολίνη. Οι συνθέσεις φαρμακολογικώς δραστικών απορρυπαντικών είναι χρήσιμες για αντιμετώπιση εντοπισμένων συσσωρεύσεων λίπους περιλαμβάνοντας κήλη λίπους στο κάτω βλέφαρο, λιποδυστροφία και εναποθέσεις λίπους οι οποίες συνδέονται με κυτταρίτιδα και δεν απαιτούν χειρουργικές διαδικασίες όπως λιποαναρρόφηση.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57287904P | 2004-05-19 | 2004-05-19 | |
EP05722895A EP1758590B1 (en) | 2004-05-19 | 2005-02-08 | Use of a detergent for the non-surgical removal of fat |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111974T1 true CY1111974T1 (el) | 2015-11-04 |
Family
ID=34961536
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101007T CY1111974T1 (el) | 2004-05-19 | 2011-10-25 | Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπους |
CY20111101044T CY1112204T1 (el) | 2004-05-19 | 2011-10-31 | Μεθοδοι και σχετικες συνθεσεις για μειωση του λιπους |
CY20181100197T CY1120146T1 (el) | 2004-05-19 | 2018-02-21 | Ενεσιμη συνθεση η οποια περιλαμβανει δεοξυχολικο νατριο |
CY2018008C CY2018008I1 (el) | 2004-05-19 | 2018-03-13 | Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπους |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101044T CY1112204T1 (el) | 2004-05-19 | 2011-10-31 | Μεθοδοι και σχετικες συνθεσεις για μειωση του λιπους |
CY20181100197T CY1120146T1 (el) | 2004-05-19 | 2018-02-21 | Ενεσιμη συνθεση η οποια περιλαμβανει δεοξυχολικο νατριο |
CY2018008C CY2018008I1 (el) | 2004-05-19 | 2018-03-13 | Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπους |
Country Status (25)
Country | Link |
---|---|
US (3) | US7622130B2 (el) |
EP (8) | EP1758590B1 (el) |
JP (2) | JP5060295B2 (el) |
KR (1) | KR101217497B1 (el) |
CN (2) | CN101018553B (el) |
AT (2) | ATE521355T1 (el) |
AU (1) | AU2005245002C1 (el) |
CA (1) | CA2567298C (el) |
CY (4) | CY1111974T1 (el) |
DK (5) | DK2422789T3 (el) |
ES (5) | ES2372499T3 (el) |
FI (1) | FI3692995T3 (el) |
FR (2) | FR20C1048I2 (el) |
HK (2) | HK1099521A1 (el) |
HU (5) | HUE038247T2 (el) |
IL (2) | IL179008A (el) |
LT (3) | LT2422789T (el) |
MX (1) | MXPA06013437A (el) |
NL (1) | NL301229I2 (el) |
NZ (2) | NZ586818A (el) |
PL (4) | PL2422789T3 (el) |
PT (5) | PT1758590E (el) |
SI (4) | SI1758590T1 (el) |
TR (1) | TR201802446T4 (el) |
WO (2) | WO2005117900A1 (el) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
ES2372499T3 (es) * | 2004-05-19 | 2012-01-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Uso de un detergente para la eliminación no quirúrgica de grasa. |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
US20060074057A1 (en) * | 2004-10-04 | 2006-04-06 | Eric Marchewitz | Use of chenodeoxycholic acid for reducing adipose tissue |
JP4646669B2 (ja) * | 2005-03-30 | 2011-03-09 | キヤノン株式会社 | 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置 |
US20060222695A1 (en) * | 2005-04-01 | 2006-10-05 | Filiberto Zadini | Deoxycholic acid liposome-based dermatological topical preparation |
US20070071706A1 (en) * | 2005-09-28 | 2007-03-29 | Filiberto Zadini | Lipodissolving dermatological topical preparation |
US20090035348A1 (en) * | 2005-11-22 | 2009-02-05 | Z & Z Medical Holdings, Inc. | Dissolution of arterial plaque |
US7676604B2 (en) * | 2005-11-22 | 2010-03-09 | Intel Corporation | Task context direct indexing in a protocol engine |
US8304383B2 (en) * | 2005-11-22 | 2012-11-06 | Atheronova Operations, Inc. | Dissolution of arterial plaque |
US20110082124A1 (en) * | 2006-02-23 | 2011-04-07 | Kythera Biopharmaceuticals, Inc. | Detergent compositions for treatment of lipomas and other conditions |
WO2008008468A2 (en) * | 2006-07-14 | 2008-01-17 | Duncan Diane I | Compositions and methods for fat reduction |
US20100063006A1 (en) * | 2006-11-22 | 2010-03-11 | American Network Of Lipolysis, Llc | Compositions and methods to reduce fat and retract skin |
DE102007015701A1 (de) * | 2007-03-19 | 2008-09-25 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung |
US8057381B2 (en) * | 2007-04-16 | 2011-11-15 | Allen Iii William F | Method and implant material for treatment of urinary incontinence |
ES2550504T3 (es) * | 2007-06-19 | 2015-11-10 | Kythera Biopharmaceuticals, Inc. | Preparación de ácido biliar sintético |
US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
US7943187B2 (en) | 2008-05-23 | 2011-05-17 | Bakr Rabie | Paeoniflorin preparations and uses thereof for fat reduction |
FR2937554B1 (fr) * | 2008-10-27 | 2010-11-12 | Yves Crassas | Solutions salines aqueuses pour la destruction de tissus graisseux |
BRPI1007812B1 (pt) * | 2009-03-02 | 2017-09-26 | Doris Maria Hexsel | Lipoatrofia cosmetic medicinal |
US10213441B2 (en) | 2009-03-02 | 2019-02-26 | Doris Hexsel | Medicinal cosmetic lipoatrophy |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
EP2485738A4 (en) * | 2009-10-09 | 2015-04-01 | Atheronova Operations Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF ADIPOSITAS |
GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
MX2013001704A (es) | 2010-08-12 | 2013-06-28 | Kythera Biopharmaceuticals Inc | Composiciones sinteticas de acido biliar y metodos. |
EP2675460A4 (en) | 2011-02-18 | 2014-07-09 | Kythera Biopharmaceuticals Inc | TREATMENT OF FAT TISSUE UNDER CHIN |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
TWI572616B (zh) | 2011-06-16 | 2017-03-01 | 凱瑟拉生物製藥有限公司 | 去氧膽酸之組成物及用途及其相關方法 |
EA034320B1 (ru) * | 2011-08-23 | 2020-01-28 | Китера Биофармасьютикалз, Инк. | Композиции дезоксихолата натрия |
PL2561876T3 (pl) | 2011-08-23 | 2014-09-30 | Kythera Biopharmaceuticals Inc | Formulacje kwasu deoksycholowego i ich sole |
CN108619089A (zh) | 2011-08-23 | 2018-10-09 | 凯瑟拉生物制药有限公司 | 脱氧胆酸和其盐的制剂 |
DK3581199T3 (da) * | 2011-10-21 | 2023-09-04 | Endo Global Ventures | Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis |
US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
EP2793813A1 (en) | 2011-12-21 | 2014-10-29 | Motolese, Pasquale | Cosmetic composition and uses thereof in the treatment of lipodystrophies |
WO2013106510A2 (en) | 2012-01-12 | 2013-07-18 | Auxilium Pharmaceuticals, Inc. | Clostridium histolyticum enzymes and methods for the use thereof |
AU2013347949A1 (en) | 2012-11-21 | 2015-06-11 | Velakine Therapeutics, Inc. | Methods and compositions for locally increasing body fat |
NO2753788T3 (el) | 2013-05-10 | 2018-06-16 | ||
WO2014186504A1 (en) | 2013-05-15 | 2014-11-20 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
WO2015179282A1 (en) | 2014-05-20 | 2015-11-26 | Topokine Therapeutics, Inc. | Topical compositions comprising a thiazolidinedione |
CN106413719A (zh) * | 2014-06-01 | 2017-02-15 | 盖尔梅德研究与发展有限公司 | 用于治疗脂肪营养不良的脂肪酸胆汁酸缀合物 |
EP3145515B1 (en) * | 2014-06-27 | 2023-07-05 | Medytox Inc. | Formulations comprising cholate and/or chenodeoxycholate for non-surgical removal of a localized fat deposit |
WO2015200425A1 (en) | 2014-06-27 | 2015-12-30 | Topokine Therapeutics, Inc. | Topical dosage regimen |
US9687455B2 (en) | 2014-08-14 | 2017-06-27 | John Daniel Dobak | Sodium tetradecyl sulfate formulations for treatment of adipose tissue |
KR20170110083A (ko) | 2014-12-23 | 2017-10-10 | 인털렉츄얼 프라퍼티 어쏘시에이츠, 엘엘씨 | 경피 투여를 위한 방법 및 제형 |
US9351945B1 (en) | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
WO2017059389A1 (en) * | 2015-10-01 | 2017-04-06 | Kythera Biopharmaceuticals, Inc. | Compositions comprising a statin for use in methods of adipolysis |
MX2018005628A (es) * | 2015-11-04 | 2018-08-01 | Kythera Biopharmaceuticals Inc | Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo. |
JP6219430B2 (ja) * | 2016-03-18 | 2017-10-25 | キテラ バイオファーマシューティカルズ,インコーポレイテッド | デオキシコール酸およびその塩類の製剤 |
EP3464315B1 (en) | 2016-06-06 | 2021-09-29 | Crystal Pharma S.A.U. | Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid |
KR101841193B1 (ko) * | 2016-09-22 | 2018-03-22 | 이경락 | 저장성 지방 분해 조성물 및 그의 제조 방법 |
US20180078621A1 (en) * | 2016-09-22 | 2018-03-22 | Kyoung Lack Lee | Composition for hypotonic lipolysis and manufacturing method thereof |
CN115969318A (zh) | 2017-03-01 | 2023-04-18 | 恩多风投有限公司 | 用于评估和治疗橘皮组织的装置和方法 |
KR102642381B1 (ko) | 2017-03-28 | 2024-02-28 | 엔도 벤쳐즈 리미티드 | 개선된 콜라게나제 생성 방법 |
CA3031678C (en) * | 2017-04-21 | 2021-08-31 | Ki Taek Lee | Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same |
KR102093872B1 (ko) * | 2017-07-03 | 2020-03-27 | 진호성 | 지방제거용 주사제 조성물 및 이의 제조방법 |
WO2019024920A1 (en) * | 2017-08-03 | 2019-02-07 | Medytox Inc. | PROCESSES FOR PREPARING BILARY ACIDS |
JP6356329B2 (ja) * | 2017-09-27 | 2018-07-11 | キテラ バイオファーマシューティカルズ,インコーポレイテッド | デオキシコール酸およびその塩類の製剤 |
KR20200087776A (ko) | 2017-10-24 | 2020-07-21 | 비오나이스, 에스.엘.유. | 데옥시콜산의 제조 방법 |
CN110302082A (zh) * | 2018-03-27 | 2019-10-08 | 上海同柏生物科技有限公司 | 用于减少身体脂肪沉积的技术及组合物制剂与应用 |
JP6594486B2 (ja) * | 2018-06-13 | 2019-10-23 | キテラ バイオファーマシューティカルズ,インコーポレイテッド | デオキシコール酸およびその塩類の製剤 |
KR102116238B1 (ko) * | 2018-08-28 | 2020-05-28 | 이경락 | 저장성 지방 분해 조성물 및 그의 제조 방법 |
WO2020081590A1 (en) | 2018-10-16 | 2020-04-23 | Rotunda Adam M | Alcohol-based compositions and uses thereof |
US11439659B2 (en) * | 2018-12-03 | 2022-09-13 | The Regents Of The University Of California | Methods and compositions to prevent and treat inflammation and allergic reactions |
KR102172439B1 (ko) * | 2018-12-05 | 2020-10-30 | 송미희 | 지방 분해용 조성물 및 이를 포함하는 주사제 조성물 |
KR102064864B1 (ko) | 2019-02-08 | 2020-01-10 | (주)제테마 | 국소 주사용 조성물 |
KR102111346B1 (ko) | 2019-08-20 | 2020-05-22 | 아영창 | 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물 |
WO2023287261A1 (ko) | 2021-07-16 | 2023-01-19 | 주식회사 스카이테라퓨틱스 | 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물 |
EP4346837A1 (en) * | 2022-07-05 | 2024-04-10 | Glonova Pharma Co., Ltd. | Injectable composition comprising cytolytic compound in gel, gel-forming solution or gel-forming suspension for reduction of fat |
Family Cites Families (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4113882A (en) * | 1974-10-21 | 1978-09-12 | Yamanouchi Pharmaceutical Co., Ltd. | Stabilized oral prostaglandin formulation and the process for the preparation thereof |
IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
US4117121A (en) * | 1977-04-22 | 1978-09-26 | Hoffmann-La Roche Inc. | Method of increasing bile flow and decreasing lipid levels |
IT8167097A0 (it) * | 1981-01-26 | 1981-01-26 | Unilever Nv | Composizione cosmetica per il trattamento della pelle o dei capelli |
US5288498A (en) * | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
GB8417895D0 (en) | 1984-07-13 | 1984-08-15 | Marples B A | Pharmaceutical anti-fungal composition |
JPS61158995A (ja) * | 1984-12-28 | 1986-07-18 | Takara Shironaga | 脂肪肝,胆石,胃粘膜障害発生の予防薬または治療薬 |
US4866044A (en) * | 1985-07-09 | 1989-09-12 | Takeda Chemical Industries, Ltd. | Solubilized composition of poorly-soluble pharmaceutical product |
IT1213453B (it) * | 1985-08-02 | 1989-12-20 | Merz & Co Gmbh & Co | Composizione farmaceutica. |
US5326562A (en) * | 1986-06-03 | 1994-07-05 | Incyte Pharmaceuticals, Inc. | Pharmaceutical dosage unit for treating inflammation comprising protease nexin-I |
US4952411A (en) | 1987-02-25 | 1990-08-28 | Trustees Of Columbia University In The City Of New York | Method of inhibiting the transmission of AIDS virus |
US5690954A (en) * | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
IL89530A0 (en) * | 1989-03-08 | 1989-09-10 | Jeffrey J Feigenbaum | Compositions containing forskolin |
GB8909022D0 (en) | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
EP0408174A1 (en) * | 1989-07-12 | 1991-01-16 | Warner-Lambert Company | Antiseptic composition containing hexahydro-5-pyrimidinamine compounds |
AU6461090A (en) | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
US5085864A (en) * | 1989-10-30 | 1992-02-04 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
CA2033725C (en) | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
US6120805A (en) * | 1990-04-06 | 2000-09-19 | Rhone-Poulenc Rorer Sa | Microspheres, process for their preparation and their use |
JP3032315B2 (ja) * | 1991-01-14 | 2000-04-17 | 健二 片桐 | 脂肪肝治療剤 |
GB9212511D0 (en) * | 1992-06-12 | 1992-07-22 | Cortecs Ltd | Pharmaceutical compositions |
US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
US5674855A (en) | 1992-08-12 | 1997-10-07 | The Rogosin Institute | Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
US6663885B1 (en) * | 1993-03-15 | 2003-12-16 | A. Natterman & Cie Gmbh | Aqueous liposome system and a method for the preparation of such a liposome system |
GB9320597D0 (en) | 1993-10-06 | 1993-11-24 | Proteus Molecular Design | Improvements in and realting to vaccines |
US5395545A (en) * | 1993-10-21 | 1995-03-07 | Akzo N.V. | Cleaning solution for automated analyzers |
CZ288146B6 (en) | 1994-12-22 | 2001-05-16 | Astra Ab | Pharmaceutical aerosol preparation, process of its preparation and use |
JP2740153B2 (ja) | 1995-03-07 | 1998-04-15 | エフ・ホフマン−ラ ロシユ アーゲー | 混合ミセル |
US5616342A (en) | 1995-04-11 | 1997-04-01 | Pdt, Inc. | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
US5759445A (en) | 1995-05-24 | 1998-06-02 | Matsushita Electric Industrial Co., Ltd. | Lipid-dispersed solution and process for producing the same |
US20040101569A1 (en) | 1996-05-16 | 2004-05-27 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
EP1024833A1 (en) | 1996-07-11 | 2000-08-09 | Farmarc Nederland B.V. | Pharmaceutical composition containing acid addition salt of basic drug |
US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
US7351421B2 (en) | 1996-11-05 | 2008-04-01 | Hsing-Wen Sung | Drug-eluting stent having collagen drug carrier chemically treated with genipin |
CA2282411A1 (en) | 1997-02-27 | 1998-09-03 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
US5891083A (en) | 1997-04-22 | 1999-04-06 | Capella; Rafael F. | Suction lipolysis |
US20020107291A1 (en) | 1997-05-26 | 2002-08-08 | Vincenzo De Tommaso | Clear, injectable formulation of an anesthetic compound |
US6197327B1 (en) * | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
EP1005324B1 (en) | 1997-06-13 | 2005-03-30 | University Of Nebraska Board Of Regents | Compositions for delivery of biological agents and methods for the preparation thereof |
US6638621B2 (en) * | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
US6281175B1 (en) * | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
US6054421A (en) * | 1997-09-23 | 2000-04-25 | Scimed Life Systems, Inc. | Medical emulsion lubricant |
US6221378B1 (en) * | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US6350458B1 (en) * | 1998-02-10 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Mixed micellar drug deliver system and method of preparation |
US20050158408A1 (en) | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
RU2224523C2 (ru) * | 1998-07-24 | 2004-02-27 | Сео Хонг Ю | Водный раствор, содержащий желчную кислоту, и способ его получения |
US7303768B2 (en) | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
TW570805B (en) * | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
US6417179B1 (en) | 1998-10-13 | 2002-07-09 | Craig G. Burkhart | Ear wax solution |
US6451286B1 (en) * | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US6375975B1 (en) * | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2000051564A1 (en) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
US6350432B1 (en) * | 1999-03-19 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Pressurized container having an aerosolized pharmaceutical composition |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6489312B1 (en) * | 1999-06-15 | 2002-12-03 | Medimmune Oncology, Inc. | Pharmaceutical formulations comprising aminoalkyl phosphorothioates |
US6225343B1 (en) * | 1999-06-16 | 2001-05-01 | Nastech Pharmaceutical Company, Inc. | Compositions and methods comprising morphine gluconate |
BR0108080A (pt) * | 2000-02-04 | 2006-02-07 | Seo Hong Yoo | Preparação de formas de dosagem de solução clara aquosa com ácidos biliares |
GB0009773D0 (en) * | 2000-04-19 | 2000-06-07 | Univ Cardiff | Particulate composition |
FR2813189B1 (fr) | 2000-08-31 | 2003-02-28 | Oreal | Creme cosmetique moussante pour le traitement des peaux grasses |
EP1317667A1 (en) * | 2000-09-08 | 2003-06-11 | Dow Global Technologies Inc. | Sequential detection ion chromatography |
EP1343492B1 (en) | 2000-11-22 | 2006-02-01 | Rxkinetix, Inc. | Treatment of mucositis |
CA2445091A1 (en) * | 2000-12-13 | 2002-06-20 | Janos Feher | Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
WO2002058610A1 (en) * | 2001-01-24 | 2002-08-01 | Summanus Pharma, Inc. | Alkyl aryl polyether alcohol polymers for improvement of nasal breathing |
SE0100901D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | New composition |
DE60233484D1 (de) | 2001-03-27 | 2009-10-08 | Phares Pharm Res Nv | Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlöslichkeit |
WO2002089849A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
CN1813699B (zh) | 2001-06-14 | 2012-04-18 | 大塚制药株式会社 | 药物组合物 |
US20030083286A1 (en) | 2001-08-22 | 2003-05-01 | Ching-Leou Teng | Bioadhesive compositions and methods for enhanced intestinal drug absorption |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
US6713470B2 (en) * | 2002-01-22 | 2004-03-30 | Ml Laboratories Plc | Method of treatment |
GB0207529D0 (en) | 2002-04-02 | 2002-05-08 | Norbrook Lab Ltd | Injectable veterinary composition for small animals |
US20040018242A1 (en) | 2002-05-06 | 2004-01-29 | Elan Pharma International Ltd. | Nanoparticulate nystatin formulations |
EP1509209A1 (en) * | 2002-05-23 | 2005-03-02 | UMD, Inc. | Compositions and method for transmucosal drug delivery and cryoprotection |
US20040220283A1 (en) * | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
BR0313060A (pt) | 2002-07-29 | 2005-06-28 | Transform Pharmaceuticals Inc | Composições farmacêuticas aquosas de 2,6-diisopropilfenol |
US20050019404A1 (en) | 2003-06-30 | 2005-01-27 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
US20050163821A1 (en) | 2002-08-02 | 2005-07-28 | Hsing-Wen Sung | Drug-eluting Biodegradable Stent and Delivery Means |
KR100482269B1 (ko) * | 2002-10-08 | 2005-04-14 | 센츄론(주) | 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법 |
CA2503956A1 (en) | 2002-10-29 | 2004-05-13 | Transform Pharmaceuticals, Inc. | Propofol with cysteine |
US20050079228A1 (en) * | 2003-05-30 | 2005-04-14 | Ashish Jaiswal | Clear, stable topical compositions of clarithromycin and processes for their preparation |
CN1894259A (zh) | 2003-08-22 | 2007-01-10 | 活跃生物工艺学公司 | 利福霉素类似物及其应用 |
DE10349979B4 (de) * | 2003-10-24 | 2006-05-18 | Sanofi-Aventis Deutschland Gmbh | Medikamentöse gezielte lokale Lipolyse |
US20050089555A1 (en) * | 2003-10-24 | 2005-04-28 | Aventis Pharma Deutschland Gmbh | Medicinal targeted local lipolysis |
JP2007515494A (ja) * | 2003-12-22 | 2007-06-14 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 注射可能なフォスファチジルコリン調製物 |
DE10361067A1 (de) | 2003-12-22 | 2005-07-14 | Aventis Pharma Deutschland Gmbh | Medikamentöse Lipolyse von Fettansammlungen |
US20050143347A1 (en) * | 2003-12-22 | 2005-06-30 | Aventis Pharma Deutschland Gmbh | Medicinal lipolysis of accumulations of fat |
KR100638041B1 (ko) | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
ES2372499T3 (es) | 2004-05-19 | 2012-01-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Uso de un detergente para la eliminación no quirúrgica de grasa. |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
FR2870741B1 (fr) | 2004-05-25 | 2008-03-14 | Coletica Sa | Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant. |
WO2005117832A1 (en) | 2004-06-03 | 2005-12-15 | Bracco Research Sa | Liposomal assembly for therapeutic and/or diagnostic use |
US20050287199A1 (en) | 2004-06-28 | 2005-12-29 | Teresa Ann Denney | Therapeutic micro nutrient composition for lipolysis and drug delivery |
WO2006007675A1 (en) * | 2004-07-20 | 2006-01-26 | Libbs Farmacêutica Ltda. | Cholic acid and/or its derivatives for the reduction of localized fat in the human body |
US20060074057A1 (en) * | 2004-10-04 | 2006-04-06 | Eric Marchewitz | Use of chenodeoxycholic acid for reducing adipose tissue |
US20060222695A1 (en) * | 2005-04-01 | 2006-10-05 | Filiberto Zadini | Deoxycholic acid liposome-based dermatological topical preparation |
-
2005
- 2005-02-08 ES ES05722895T patent/ES2372499T3/es active Active
- 2005-02-08 EP EP05722895A patent/EP1758590B1/en active Active
- 2005-02-08 EP EP11166225.0A patent/EP2422789B1/en active Active
- 2005-02-08 PT PT05722895T patent/PT1758590E/pt unknown
- 2005-02-08 HU HUE11166225A patent/HUE038247T2/hu unknown
- 2005-02-08 MX MXPA06013437A patent/MXPA06013437A/es active IP Right Grant
- 2005-02-08 US US11/054,171 patent/US7622130B2/en active Active
- 2005-02-08 AT AT05722895T patent/ATE521355T1/de active
- 2005-02-08 WO PCT/US2005/004184 patent/WO2005117900A1/en active Application Filing
- 2005-02-08 ES ES11166225.0T patent/ES2660172T3/es active Active
- 2005-02-08 SI SI200531417T patent/SI1758590T1/sl unknown
- 2005-02-08 SI SI200532194T patent/SI2422789T1/en unknown
- 2005-02-08 DK DK11166225.0T patent/DK2422789T3/en active
- 2005-02-08 EP EP12189943A patent/EP2550968A1/en not_active Withdrawn
- 2005-02-08 PL PL11166225T patent/PL2422789T3/pl unknown
- 2005-02-08 TR TR2018/02446T patent/TR201802446T4/tr unknown
- 2005-02-08 EP EP18185014.0A patent/EP3424508B1/en active Active
- 2005-02-08 DK DK05722895.9T patent/DK1758590T3/da active
- 2005-02-08 PT PT111662250T patent/PT2422789T/pt unknown
- 2005-02-08 PL PL05722895T patent/PL1758590T3/pl unknown
- 2005-02-08 LT LTEP11166225.0T patent/LT2422789T/lt unknown
- 2005-05-19 ES ES11166230T patent/ES2795749T3/es active Active
- 2005-05-19 AT AT05751896T patent/ATE518565T1/de active
- 2005-05-19 PL PL20166727.6T patent/PL3692995T3/pl unknown
- 2005-05-19 PT PT05751896T patent/PT1748780E/pt unknown
- 2005-05-19 PT PT201667276T patent/PT3692995T/pt unknown
- 2005-05-19 NZ NZ586818A patent/NZ586818A/xx unknown
- 2005-05-19 NZ NZ551000A patent/NZ551000A/en unknown
- 2005-05-19 EP EP12189947A patent/EP2572718A1/en not_active Withdrawn
- 2005-05-19 JP JP2007527519A patent/JP5060295B2/ja active Active
- 2005-05-19 SI SI200531400T patent/SI1748780T1/sl unknown
- 2005-05-19 KR KR1020067023922A patent/KR101217497B1/ko active IP Right Review Request
- 2005-05-19 PL PL05751896T patent/PL1748780T3/pl unknown
- 2005-05-19 CN CN200580015906.XA patent/CN101018553B/zh active Active
- 2005-05-19 WO PCT/US2005/017957 patent/WO2005112942A1/en active Application Filing
- 2005-05-19 HU HUE20166727A patent/HUE061343T2/hu unknown
- 2005-05-19 LT LTEP11166230.0T patent/LT2380576T/lt unknown
- 2005-05-19 PT PT111662300T patent/PT2380576T/pt unknown
- 2005-05-19 EP EP11166230.0A patent/EP2380576B1/en active Active
- 2005-05-19 ES ES05751896T patent/ES2372416T3/es active Active
- 2005-05-19 EP EP20166727.6A patent/EP3692995B1/en active Active
- 2005-05-19 DK DK05751896.1T patent/DK1748780T3/da active
- 2005-05-19 CA CA2567298A patent/CA2567298C/en active Active
- 2005-05-19 FI FIEP20166727.6T patent/FI3692995T3/fi active
- 2005-05-19 HU HUE11166230A patent/HUE049990T2/hu unknown
- 2005-05-19 DK DK11166230.0T patent/DK2380576T3/da active
- 2005-05-19 SI SI200532276T patent/SI2380576T1/sl unknown
- 2005-05-19 DK DK20166727.6T patent/DK3692995T3/da active
- 2005-05-19 AU AU2005245002A patent/AU2005245002C1/en active Active
- 2005-05-19 ES ES20166727T patent/ES2939383T3/es active Active
- 2005-05-19 CN CN201510621591.9A patent/CN105233287A/zh active Pending
- 2005-05-19 EP EP05751896A patent/EP1748780B1/en active Active
-
2006
- 2006-03-13 US US11/375,173 patent/US20060154906A1/en not_active Abandoned
- 2006-11-02 IL IL179008A patent/IL179008A/en unknown
-
2007
- 2007-06-27 HK HK07106866.1A patent/HK1099521A1/xx unknown
- 2007-08-14 HK HK07108856.9A patent/HK1101062A1/xx unknown
-
2009
- 2009-10-28 US US12/607,882 patent/US8298556B2/en active Active
-
2010
- 2010-07-21 IL IL207126A patent/IL207126A/en active IP Right Grant
-
2011
- 2011-10-25 CY CY20111101007T patent/CY1111974T1/el unknown
- 2011-10-31 CY CY20111101044T patent/CY1112204T1/el unknown
-
2012
- 2012-05-07 JP JP2012105708A patent/JP2012176966A/ja active Pending
-
2017
- 2017-01-23 HU HUS1700004C patent/HUS1700004I1/hu unknown
- 2017-03-08 LT LTPA2017006C patent/LTPA2017006I1/lt unknown
-
2018
- 2018-02-21 CY CY20181100197T patent/CY1120146T1/el unknown
- 2018-03-13 CY CY2018008C patent/CY2018008I1/el unknown
-
2020
- 2020-10-07 FR FR20C1048C patent/FR20C1048I2/fr active Active
-
2023
- 2023-04-26 NL NL301229C patent/NL301229I2/nl unknown
- 2023-04-26 HU HUS2300016C patent/HUS2300016I1/hu unknown
- 2023-04-28 FR FR23C1018C patent/FR23C1018I1/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111974T1 (el) | Χρηση ενος απορρυπαντικου για τη μη-χειρουργικη αφαιρεση λιπους | |
CY1105078T1 (el) | Ανταγωνιστες τεκ | |
UY27711A1 (es) | Compuestos útiles en terapia | |
CY1110863T1 (el) | Παραγωγα του 2-(8,9-διοξο-2,6-διαζαδικυκλο (5.2.0)-εννε-1(7)-εν-2-υλ)αλκυλ-φωσφονικου οξεος και η χρηση τους ως ανταγωνιστων του ν-μεθυλ- d-ασπαρτικου (nmda) υποδοχεα | |
NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
TR201900542T4 (tr) | Ağrı ve/veya enflamasyon tedavisi için bileşimler. | |
CY1108874T1 (el) | ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ | |
CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
CY1105533T1 (el) | Νεα χρηση μιας ενωσης κλασης πεπτιδιου για την θεραπευτικη αντιμετωπιση μη-νευροπαθους φλεγμονωδους πονου | |
GB0223040D0 (en) | Therapeutic compounds | |
CY1105591T1 (el) | Αναστολεις για συνθαση του 20-ηετε | |
DE60106409D1 (de) | 3-aminopyrazole als inhibitoren von cyclinabhängigen kinasen | |
UY27034A1 (es) | Derivados de pirimidina | |
DE50304342D1 (de) | Beleuchtung für Operationsmikroskope zum Schutz von menschlichem Gewebe | |
DK1545710T3 (da) | Anvendelse af N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]-phenyl)-pyridin-3-sulfonamid til behandling af cancer | |
CY1109771T1 (el) | Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες | |
CY1106540T1 (el) | Ετεροκυλικα υποκατεστημενες στη θεση 3 πιπεριδινο-2,6-διονες | |
RU2004112266A (ru) | Хирургический доступ к надпочечникам |